Search research articles
Contact Us
Filters
Showing results (11-20 of 145) with videos related to
Page
of 15
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
November 29, 2011
Diverting ileostomies: primum minus nocere (first, do less harm)
Anton Bilchik, Mark B Faries
Surgical Oncology Clinics of North America
|
June 3, 2020
Sentinel Lymph Node Biopsy: Indications and Technique
Jessica Crystal, Mark B Faries
Annals of Surgical Oncology
|
February 22, 2023
Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut Back
Mark B Faries, Giorgos Karakousis
Current Problems in Cancer
|
September 14, 2011
Current surgical treatment in melanoma
Mark B Faries, Stephan Ariyan
Cancers
|
November 9, 2024
Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions
Eric Pletcher, Mark B Faries
Surgical Oncology
|
November 18, 2024
Melanoma sentinel lymph node biopsy in the modern era
Teodora Dumitra, Mark B Faries
Annals of Surgical Oncology
|
June 11, 2020
Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
Giorgos C Karakousis, Mark B Faries
Annals of Surgical Oncology
|
September 14, 2018
Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed
Jamie Green Rand, Mark B Faries
Annals of Surgical Oncology
|
May 2, 2022
ASO Author Reflections: Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma
James W Jakub, Mark B Faries
Current Treatment Options in Oncology
|
May 5, 2005
Dendritic cells in melanoma immunotherapy
Mark B Faries, Brian J Czerniecki
Page
of 15
Search research articles
Search
Showing results (11-20 of 145) with videos related to
Sort By:
Page
of 15
Archives of Surgery (Chicago, Ill. : 1960)
|
November 29, 2011
Diverting ileostomies: primum minus nocere (first, do less harm)
Anton Bilchik, Mark B Faries
Surgical Oncology Clinics of North America
|
June 3, 2020
Sentinel Lymph Node Biopsy: Indications and Technique
Jessica Crystal, Mark B Faries
Annals of Surgical Oncology
|
February 22, 2023
Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut Back
Mark B Faries, Giorgos Karakousis
Current Problems in Cancer
|
September 14, 2011
Current surgical treatment in melanoma
Mark B Faries, Stephan Ariyan
Cancers
|
November 9, 2024
Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions
Eric Pletcher, Mark B Faries
Surgical Oncology
|
November 18, 2024
Melanoma sentinel lymph node biopsy in the modern era
Teodora Dumitra, Mark B Faries
Annals of Surgical Oncology
|
June 11, 2020
Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
Giorgos C Karakousis, Mark B Faries
Annals of Surgical Oncology
|
September 14, 2018
Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed
Jamie Green Rand, Mark B Faries
Annals of Surgical Oncology
|
May 2, 2022
ASO Author Reflections: Minimally Invasive Inguinal Lymphadenectomy, an Incremental Step in the Evolution of the Management of Advanced Melanoma
James W Jakub, Mark B Faries
Current Treatment Options in Oncology
|
May 5, 2005
Dendritic cells in melanoma immunotherapy
Mark B Faries, Brian J Czerniecki
Page
of 15